본문 바로가기
KERD
논문KCI 등재

Multimodality Imaging for Left Ventricular Hypertrophy Severity Grading: A Methodological Review

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류내과학

초록

Left ventricular hypertrophy (LVH), defined by an increase in left ventricular mass (LVM), is a common cardiac finding generally caused by an increase in pressure or volume load. Assessing severity of LVH is of great clinical value in terms of prognosis and treatment choices, as LVH severity grades correlate with the risk for presenting cardiovascular events. The three main cardiac parameters for the assessment of LVH are wall thickness, LVM, and LV geometry. Echocardiography, with large availability and low cost, is the technique of choice for their assessment. Consequently, reference values for LVH severity in clinical guidelines are based on this technique. However, cardiac magnetic resonance (CMR) and computed tomography (CT) are increasingly used in clinical practice, providing excellent image quality. Nevertheless, there is no extensive data to support reference values based on these techniques, while comparative studies between the three techniques show different results in wall thickness and LVM measurements. In this paper, we provide an overview of the different methodologies used to assess LVH severity with echocardiography, CMR and CT. We argue that establishing reference values per imaging modality, and possibly indexed to body surface area and classified per gender, ethnicity and age-group, might be essential for the correct classification of LVH severity.

Abstract

Left ventricular hypertrophy (LVH), defined by an increase in left ventricular mass (LVM), is a common cardiac finding generally caused by an increase in pressure or volume load. Assessing severity of LVH is of great clinical value in terms of prognosis and treatment choices, as LVH severity grades correlate with the risk for presenting cardiovascular events. The three main cardiac parameters for the assessment of LVH are wall thickness, LVM, and LV geometry. Echocardiography, with large availability and low cost, is the technique of choice for their assessment. Consequently, reference values for LVH severity in clinical guidelines are based on this technique. However, cardiac magnetic resonance (CMR) and computed tomography (CT) are increasingly used in clinical practice, providing excellent image quality. Nevertheless, there is no extensive data to support reference values based on these techniques, while comparative studies between the three techniques show different results in wall thickness and LVM measurements. In this paper, we provide an overview of the different methodologies used to assess LVH severity with echocardiography, CMR and CT. We argue that establishing reference values per imaging modality, and possibly indexed to body surface area and classified per gender, ethnicity and age-group, might be essential for the correct classification of LVH severity.

참고문헌 (58)

  1. Cuspidi C, "Prevalence of left-ventricular hypertrophy in hypertension : an updated review of echocardiographic studies", J Hum Hypertens, 26, pp.343~349 (2012)
  2. Ruilope LM, "Left ventricular hypertrophy and clinical outcomes in hypertensive patients", Am J Hypertens, 21, pp.500~508 (2008)
  3. Cuspidi C, "Left-ventricular hypertrophy and obesity : a systematic review and meta-analysis of echocardiographic studies", J Hypertens, 32, pp.16~25 (2014)
  4. de Simone G, "Left ventricular geometry in obesity: is it what we expect?", Nutr Metab Cardiovasc Dis, 23, pp.905~912 (2013)
  5. Chobanian AV, "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report", JAMA, 289, pp.2560~2572 (2003)
  6. Marwick TH, "Recommendations on the use of echocardiography in adult hypertension : a report from the European Association of Cardiovascular Imaging(EACVI)and the American Society of Echocardiography(ASE)", J Am Soc Echocardiogr, 28, pp.727~754 (2015)
  7. Rader F, "Left ventricular hypertrophy in valvular aortic stenosis : mechanisms and clinical implications", Am J Med, 128, pp.344~352 (2015)
  8. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), "Guidelines on the management of valvular heart disease(version 2012)", Eur Heart J, 33, pp.2451~2496 (2012)
  9. Bekeredjian R, "Valvular heart disease : aortic regurgitation", Circulation, 112, pp.125~134 (2005)
  10. Gaasch WH, "Left ventricular response to mitral regurgitation : implications for management", Circulation, 118, pp.2298~2303 (2008)
  11. Task Force members, "2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy : the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology(ESC)", Eur Heart J, 35, pp.2733~2779 (2014)
  12. Linhart A, "The heart in Anderson-Fabry disease and other lysosomal storage disorders", Heart, 93, pp.528~535 (2007)
  13. Charron P, "Genetic counselling and testing in cardiomyopathies : a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases", Eur Heart J, 31, pp.2715~2726 (2010)
  14. Yilmaz A, "Diagnostic approach and differential diagnosis in patients with hypertrophied left ventricles", Heart, 100, pp.662~671 (2014)
  15. Batterham AM, "Growth of left ventricular mass with military basic training in army recruits", Med Sci Sports Exerc, 43, pp.1295~1300 (2011)
  16. Naylor LH, "The athlete’s heart : a contemporary appraisal of the ‘Morganroth hypothesis’", Sports Med, 38, pp.69~90 (2008)
  17. Zalawadiya SK, "Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults", Eur J Prev Cardiol, 22, pp.673~679 (2015)
  18. Lang RM, "Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging", Eur Heart J Cardiovasc Imaging, 16, pp.233~270 (2015)
  19. Lawrence JP, "Physics and instrumentation of ultrasound", Crit Care Med, 35(8 Suppl), pp.S314~S322 (2007)
  20. Klitsie LM, "Ventricular performance after surgery for a congenital heart defect as assessed using advanced echocardiography : from doppler flow to 3D echocardiography and speckletracking strain imaging", Pediatr Cardiol, 35, pp.3~15 (2014)
  21. Hoey ET, "Multi-detector CT angiography of the aortic valvepart 1: anatomy, technique and systematic approach to interpretation", Quant Imaging Med Surg, 4, pp.265~272 (2014)
  22. Te Riele AS, "Noninvasive multimodality imaging in ARVD", C, 2015, pp.8, 597~611
  23. Kusunose K, "Comparison of three-dimensional echocardiographic findings to those of magnetic resonance imaging for determination of left ventricular mass in patients with ischemic and non-ischemic cardiomyopathy", Am J Cardiol, 112, pp.604~611 (2013)
  24. Chang SA, "Assessment of left ventricular mass in hypertrophic cardiomyopathy by real-time three-dimensional echocardiography using single-beat capture image", J Am Soc Echocardiogr, 26, pp.436~442 (2013)
  25. Shimada YJ, "Meta-analysis of accuracy of left ventricular mass measurement by three-dimensional echocardiography", Am J Cardiol, 110, pp.445~452 (2012)
  26. Mizukoshi K, "Normal values of left ventricular mass index assessed by transthoracic three-dimensional echocardiography", J Am Soc Echocardiogr, 29, pp.51~61 (2016)
  27. Geva T, "Magnetic resonance imaging : historical perspective", J Cardiovasc Magn Reson, 8, pp.573~580 (2006)
  28. Young AA, "Cardiovascular magnetic resonance : deeper insights through bioengineering", Annu Rev Biomed Eng, 15, pp.433~461 (2013)
  29. Goldman LW, "Principles of CT and CT technology", J Nucl Med Technol, 35, pp.115~128 (2007)
  30. Sun Z, "Coronary CT angiography with prospective ECG-triggering: an effective alternative to invasive coronary angiography", Cardiovasc Diagn Ther, 2, pp.28~37 (2012)
  31. Task Force members, "2014 ESC", EACTS Guidelines on myocardial revascularization : The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI), 2014, pp.35, 2541~2619
  32. Douglas PS, "Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR (CT): outcome and resource impacts study", Eur Heart J, 36, pp.3359~3367 (2015)
  33. Gonçalves Pde A, "Functional evaluation of coronary disease by CT angiography", JACC Cardiovasc Imaging, 8, pp.1322~1335 (2015)
  34. Gebker R, "Influence of left ventricular hypertrophy and geometry on diagnostic accuracy of wall motion and perfusion magnetic resonance during dobutamine stress", Circ Cardiovasc Imaging, 3, pp.507~514 (2010)
  35. Budoff MJ, "Determination of left ventricular mass on cardiac computed tomographic angiography", Acad Radiol, 16, pp.726~732 (2009)
  36. Salton CJ, "Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort", J Am Coll Cardiol, 39, pp.1055~1060 (2002)
  37. Stolzmann P, "Left ventricular and left atrial dimensions and volumes : comparison between dual-source CT and echocardiography", Invest Radiol, 43, pp.284~289 (2008)
  38. Barbieri A, "Left ventricular hypertrophy reclassification and death : application of the Recommendation of the American Society of Echocardiography", European Association of Echocardiography, 2012, pp.13, 109~117
  39. Bogaert J, "Clinical Cardiac MRI" (2004), Springer Science & Business Media
  40. "Clinical Packages: CT Cardiac 2016" (2016)[URL]
  41. Bang CN, "Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients", Circ Cardiovasc Imaging, 7, pp.422~429 (2014)
  42. Garg S, "Refining the classification of left ventricular hypertrophy to provide new insights into the progression from hypertension to heart failure", Curr Opin Cardiol, 31, pp.387~393 (2016)
  43. Bicudo LS, "Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy : comparison with two-dimensional echocardiography and magnetic resonance imaging", Echocardiography, 25, pp.717~726 (2008)
  44. Malagò R, "MDCT coronary angiography vs 2D echocardiography for the assessment of left ventricle functional parameters", Radiol Med, 116, pp.505~520 (2011)
  45. Butler J, "Comparison of multidetector computed tomography and two-dimensional transthoracic echocardiography for left ventricular assessment in patients with heart failure", Am J Cardiol, 99, pp.247~249 (2007)
  46. Puntmann VO, "Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance : comparison with transthoracic echocardiography", Eur Heart J Cardiovasc Imaging, 14, pp.240~246 (2013)
  47. Rickers C, "Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy", Circulation, 112, pp.855~861 (2005)
  48. Zhao L, "Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy : multidetector computed tomography versus magnetic resonance imaging", Eur J Radiol, 83, pp.1778~1785 (2014)
  49. Zhao L, "Diagnostic performance of computed tomography for detection of concomitant coronary disease in hypertrophic cardiomyopathy", Eur Radiol, 25, pp.767~775 (2015)
  50. Kanza RE, "Quantitative assessment of regional left ventricular wall thickness and thickening using 16 multidetector-row computed tomography : comparison with cine magnetic resonance imaging", Radiat Med, 25, pp.119~126 (2007)
  51. Fischbach R, "Assessment of regional left ventricular function with multidetector-row computed tomography versus magnetic resonance imaging", Eur Radiol, 17, pp.1009~1017 (2007)
  52. Kühl HP, "M-mode echocardiography overestimates left ventricular mass in patients with normal left ventricular shape : a comparative study using three-dimensional echocardiography", Eur J Echocardiogr, 4, pp.312~319 (2003)
  53. Bezante GP, "Left ventricular myocardial mass determination by contrast enhanced colour Doppler compared with magnetic resonance imaging", Heart, 91, pp.38~43 (2005)
  54. Gruszczyńska K, "Statistical agreement of left ventricle measurements using cardiac magnetic resonance and 2D echocardiography in ischemic heart failure", Med Sci Monit, 18, pp.MT19~MT25 (2012)
  55. Chuang ML, "Three-dimensional echocardiographic measurement of left ventricular mass : comparison with magnetic resonance imaging and two-dimensional echocardiographic determinations in man", Int J Card Imaging, 16, pp.347~357 (2000)
  56. Greupner J, "Headto-head comparison of left ventricular function assessment with 64-row computed tomography, biplane left cineventriculography, and both 2- and 3-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging as the reference standard", J Am Coll Cardiol, 59, pp.1897~1907 (2012)
  57. Faletti R, "Cardiovascular magnetic resonance as a reliable alternative to cardiovascular computed tomography and transesophageal echocardiography for aortic annulus valve sizing", Int J Cardiovasc Imaging, 32, pp.1255~1263 (2016)
  58. Mongeon FP, "Multimodality noninvasive imaging of thoracic aortic aneurysms: time to standardize?", Can J Cardiol, 32, pp.48~59 (2016)

관련 논문AI추천

이 간행물의 다른 논문 (14건)